The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource

Journal of the National Cancer Institute

Volumn 105, Issue 22, 2013, Pages 1684-1693

  Zhu, Claire S ^a   Pinsky, Paul F ^a   Kramer, Barnett S ^a   Prorok, Philip C ^a   Purdue, Mark P ^b   Berg, Christine D ^a   Gohagan, John K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD SAMPLING; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; COLORECTAL CANCER; DIGITAL RECTAL EXAMINATION; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; LUNG CANCER; OVARY CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; THORAX RADIOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 84890487526     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt281     Document Type: Review

References (18)

1. Gohagan JK, Prorok PC, Hayes RB, et al. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21(6 Suppl):251S-272S.
2. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl):273S-309S.
3. Andriole GL, Grubb RL, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. New Engl J Med. 2009;360(13): 1310-1319.
4. Andriole GL, Crawford ED, Grubb RL, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2011;104(2):125-132.
5. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295-2302.
6. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306(17):1865-1873.
7. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl J Med. 2011;366(25):2345-2357.
8. O'Brien B, Nichaman L, Browne J, Levin D, Prorok P, Gohagan J. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl): 273S-309S.
9. Molinari JF, Molinari A. A new methodology for ranking scientific institutions. Scientometrics. 2008;75(1):163-174.
10. Moyer VA, US Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134.
11. Schroder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. New Eng J Med. 2012;366(11):981-990
12. Moyer VA, US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
13. Moyer VA, US Preventive Services Task Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900-904.
14. Johnston SC, Rootenberg JD, Katrak S, Smith WS, Elkins JS. Effect of a US National Institutes of Health programme of clinical trials on public health and costs. Lancet. 2006;367(9519):1319-1327.
15. Heijnsdijk EAM, der Kinderen A, Wever EM, Draisma G, Roobol MJ, de Koning HJ. Overdetection, overtreatment and costs of prostate-Antigen screening for prostate cancer. Br J Cancer. 2009;101(11):1833-1838.
16. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nature Rev Cancer. 2005;5(5):388-396.
17. Colditz GA, Winn DM. Criteria for the evaluation of large cohort studies: An application to the Nurses' Health Study. J Natl Cancer Inst. 2008;100(13):918-925.
18. Hendrix D. An analysis of bibliometric indicators, National Institutes of Health funding, and faculty size at Association of American Medical Colleges medical schools, 1997-2007. J Med Lib Assoc. 2008;96(4): 324-334.